Protagenic Therapeutics, Inc.\new Increase (Decrease) in Inventories
Protagenic Therapeutics, Inc.\new (PTIX) reported Increase (Decrease) in Inventories of $26 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new increase (decrease) in inventories for the quarter ending 2026-03-31 was -$10.00, a 127.03% decline year-over-year.
- Protagenic Therapeutics, Inc.\new increase (decrease) in inventories for the quarter ending 2025-12-31 was -$1.00.
- Protagenic Therapeutics, Inc.\new increase (decrease) in inventories for the quarter ending 2025-09-30 was -$20.00, a 132.26% decline year-over-year.
- Protagenic Therapeutics, Inc.\new increase (decrease) in inventories for the quarter ending 2025-06-30 was $57.00, a 2750.00% increase year-over-year.
- Protagenic Therapeutics, Inc.\new increase (decrease) in inventories for fiscal 2026 was $26.00, a 10.34% decline from fiscal 2025.
- Protagenic Therapeutics, Inc.\new increase (decrease) in inventories for fiscal 2025 was $29.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$10.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | -$11.00 derived: sum of 2 quarters · filed 2026-08-14 | -$31.00 derived: sum of 3 quarters · filed 2026-08-14 | $26.00 10-K · filed 2026-08-14 |
| 2025-12-31 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | -$21.00 derived: sum of 2 quarters · filed 2026-03-09 | $36.00 10-Q · filed 2026-03-09 | $73.00 derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | -$20.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-26 | $37.00 10-Q · filed 2025-11-26 | $74.00 derived: sum of 3 quarters · filed 2026-08-19 | $2.00 derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $57.00 10-Q · filed 2026-08-19 | $94.00 derived: sum of 2 quarters · filed 2026-08-19 | $22.00 derived: sum of 3 quarters · filed 2026-08-19 | $84.00 derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $37.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | -$35.00 derived: sum of 2 quarters · filed 2026-08-14 | $27.00 derived: sum of 3 quarters · filed 2026-08-14 | $29.00 10-K · filed 2026-08-14 |
| 2024-12-31 | -$72.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | -$10.00 derived: sum of 2 quarters · filed 2026-03-09 | -$8.00 10-Q · filed 2026-03-09 | |
| 2024-09-30 | $62.00 derived: 10-Q 6 month − 10-QT 3 month · filed 2025-11-26 | $64.00 10-Q · filed 2025-11-26 | ||
| 2024-06-30 | $2.00 10-QT · filed 2025-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |